Patents by Inventor Aniko Miklosne Kovacs

Aniko Miklosne Kovacs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
    Patent number: 7098210
    Abstract: The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel compounds possess neuroleptic effect and can be used, primarily, for the treatment of schizophrenia. In formula I, R stands for a hydrogen atom or a C1-4, alkyl group, X and Y represent, independently, a hydrogen atom, a halogen atom or a group of the formula II, with the proviso that one of X and Y means always a group of the formula II, and then the other one stands for a hydrogen atom or a halogen atom, wherein in formula II n has a value of 1 or 2.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: August 29, 2006
    Assignee: Egis Gyógyszergyár Rt.
    Inventors: József Barkóczy, Péter Kótay Nagy, Gyula Simig, György Lévay, István Gacsályi, András Egyed, Judit Ráczné Bajnógel, Katalin Pallagi, Éva Schmidt, Gábor Szénási, Anikó Miklósné Kovács, János Wellmann
  • Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
    Patent number: 6930110
    Abstract: The invention relates to substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R1 is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R2 is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R3 stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C1-4 alkyl); Z stands for oxygen; or R3 and Z together with the groups placed between them form a piperazine ring; and R4 stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: August 16, 2005
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: József Barkóczy, András Egyed, István Gacsályi, László Hársing, Hajnalka Kompagne, Péter Kótay Nagy, György Lévay, Csilla Leveleki, Bernadett Martonné Markó, Anikó Miklósné Kovács, Éva Schmidt, Gyula Simig, Gábor Szénási, János Wellmann
  • Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
    Publication number: 20050043314
    Abstract: New substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R1 is hydrogen or alkyl having 1-4 carbon atoms; X is hydrogen or halogen; R2 is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; Q and W independently from each other stand for —N? or —CH?; and R4 and R5 independently from each other represent hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof possess useful anxiolytic and cognition enhancing properties.
    Type: Application
    Filed: September 26, 2002
    Publication date: February 24, 2005
    Inventors: Jozsef Barkoczy, Andras Egyed, Istvan Gacsalyi, Laszlo Harsing, Hajnalka Kompagne, Peter Kotay Nagy, Gyorgy Levay, Csilla Leveleki, Bernadett Martonne Marko, Aniko Miklosne Kovacs, Eva Schmidt, Gyula Simig, Gabor Szenasi, Janos Wellmann
  • Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
    Publication number: 20040242873
    Abstract: The invention relates to new substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R1 is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R2 is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R3 stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C1-4 alkyl); Z stands for oxygen; or R3 and Z together with the groups placed between them form a piperazine ring; and R4 stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.
    Type: Application
    Filed: June 28, 2004
    Publication date: December 2, 2004
    Inventors: Jozsef Barkoczy, Andras Egyed, Istvan Gacsalyi, Laszlo Harsing, Hajnalka Kompagne, Peter Kotay Nagy, Gyorgy Levay, Csilla Leveleki, Bernadett Martonne Marko, Aniko Miklosne Kovacs, Eva Schmidt, Gyula Simig, Gabor Szenasi, Janos Wellmann
  • Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
    Publication number: 20040186170
    Abstract: The present invention is a piperazinylalkylbenzofuran derivative of the formula 1
    Type: Application
    Filed: December 15, 2003
    Publication date: September 23, 2004
    Applicant: EGIS GYOGYSZERGYAR
    Inventors: Katalin Ivanicsne Megyeri, Aniko Miklosne Kovacs, Ildiko Nagyne Gyonos, Bela Agai, Jozsef Reiter, Gyula Simig, Endre Rivo, Zoltan Tamas Nagy, Levente Ondi, Szabolcs Keriesz, Gabor Szenasi, Eva Schmidt, Katalin Pallagi, Istvan Gacsalyi, Istvan Gyeriyan, Tamas Szabados, Gyorgy Levay, Andras Egyed
  • Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
    Publication number: 20040171619
    Abstract: The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel compounds possess neuroleptic effect and can be used, primarily, for the treatment of schizophrenia. In formula I, R stands for a hydrogen atom or a C1-4, alkyl group, X and Y represent, independently, a hydrogen atom, a halogen atom or a group of the formula II, with the proviso that one of X and Y means always a group of the formula II, and then the other one stands for a hydrogen atom or a halogen atom, wherein in formula II n has a value of 1 or 2.
    Type: Application
    Filed: April 23, 2004
    Publication date: September 2, 2004
    Inventors: Jozsef Barkoczy, Peter Kotay Nagy, Gyula Simig, Gyorgy Levay, Istvan Gacsalyi, Andras Egyed, Judit Raczne Bajnogel, Katalin Pallagi, Eva Schmidt, Gabor Szenasi, Aniko Miklosne Kovacs, Janos Wellmann
  • 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the C.N.S. and the heart
    Patent number: 6191152
    Abstract: The invention refers to novel 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives of formula (I) having an influence on the heart and the central nervous system, furthermore pharmaceutical compositions containing the above derivatives, and a process for the preparations of the novel compounds.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: February 20, 2001
    Assignee: EGIS Gyógyszergyar Rt.
    Inventors: József Reiter, József Barkóczy, Gábor Berecz, Gyula Simig, András Egyed, Katalin Ivanicsné Megyeri, Sándor Drabant, Szabolcs Kertész, Anikó Miklósné Kovács, Ildikó Nagyné Gyönös, Mária Szécseyné Hegedüs, Gábor Szénási, János Wellmann, Katalin Pallagi, Éva Schmidt, Károly Tihanyi, Péter Trinka, Margit Csörgö